CATX

Lori A. Woods

Known title: CEOCIK: 0001393007

Lori A. Woods's purchase track record

How the stock did after each of Lori A. Woods's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
6
of 6 since June 7, 2022
Stock higher 6 months later
67%
3 months: 100%
Median 6-month return
+39.8%
3 months: +31.3%
Beat the S&P 500
67%
median +34.4% vs. index
PurchaseStockAmount3 months6 months
3/31/2025CATX$50K+61.5%+57.3%
6/14/2024CATX$50K+41.1%-67.5%
6/3/2024CATX$50K+3.5%-69.7%
12/14/2023CATX$50K+282.1%+314.3%
11/15/2022CATX$34K+18.2%+54.5%
6/7/2022CATX$22K+21.4%+25.0%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 26, 2026

CATX included in pre-market movers list. Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.

this person other insiders at CATX

Transaction History

CATX▲ Buy$50K
CATX▲ Buy$49K
CATX▲ Buy$896
CATX▲ Buy$50K
CATX▲ Buy$41K
CATX▲ Buy$9K
CATX▲ Buy$14K
CATX▲ Buy$100K
CATX▲ Buy$34K
CATX▲ Buy$22K
CATX▲ Buy$29K
CATX▲ Buy$27K

We use analytics to understand how market-wall is used. No personal data is sold.